Kejun Cheng
FDA investigator
Appears on 2 documents from 2019 to 2025, mostly at sites in India. Most often cites general requirements (21 CFR 211.160).
- 2
- Documents on file
- 4.5
- Observations per 483
- 2019
- First seen
- 2025
- Most recent
What they cite most
From 9 observations- 21 CFR 211.160General requirements3
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.67Equipment cleaning and maintenance1
- 21 CFR 820.30Design controls1
Activity by year
2019: 1, 2025: 1
Where
India 1 · Ireland 1
Often inspects with
Is Kejun Cheng coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-01-30 | 483 Allergan Pharmaceuticals Ireland UnlimitedJan 30, 2025 · Westport, Ireland | Westport, Ireland | 5 | |
| 2019-06-11 | 483 Sun Pharmaceutical Industries Ltd.Jun 11, 2019 · Halol, India | Halol, India | 4 |
About this profile
What does Kejun Cheng inspect?
Kejun Cheng appears on 2 documents on file covering 2 sites, mostly in India.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.110 and 21 CFR 211.113.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Kejun Cheng is dated Jan 30, 2025.